• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KRAS基因3'-非翻译区的一个变体破坏了它与hsa-let-7g的相互作用,并促进慢性阻塞性肺疾病(COPD)患者肺癌的发生。

A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.

作者信息

Hu Hua, Zhang Linlin, Teng Geling, Wu Yanhua, Chen Ying

机构信息

The Respiratory Department, Shandong Provincial Chest Hospital, Jinan, Shandong, People's Republic of China.

The Clinical Laboratory of Shandong Provincial Chest Hospital, Jinan, Shandong, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2015 Aug 17;10:1641-9. doi: 10.2147/COPD.S83596. eCollection 2015.

DOI:10.2147/COPD.S83596
PMID:26316738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4544728/
Abstract

OBJECTIVE

The objective of the present study was to explore the molecular mechanism by which a single nucleotide polymorphism (rs712) interferes with interaction between 3'-untranslated region (3'-UTR) of KRAS and let-7g, and its association with development of lung cancer in the patients with COPD.

MATERIALS AND METHODS

In this study, we confirmed that KRAS is a target of let-7g in lung cancer cells, and that introduction of rs712 minor allele into 3'-UTR significantly compromised the miRNA/mRNA interaction by using a luciferase reporter system. Additionally, a total of 35 lung tissue samples were obtained (TT:17, TG:12, GG:6), and let-7g and KRAS expression levels were determined.

RESULTS

We showed that let-7g level was similar between groups, and the concentration of KRAS in GG genotype group was significantly higher than in TT or GT genotype group. Meanwhile, we found COPD patients with GG genotype had significantly higher risk for lung cancer (odds ratio OR =6.83, P=0.0081), compared with TT and GT genotypes.

CONCLUSION

Our study demonstrated that KRAS 3'-UTR rs712 polymorphism interfered with miRNA/mRNA interaction, and showed that the minor allele was associated with an elevated risk for development of lung cancer in COPD.

摘要

目的

本研究旨在探讨单核苷酸多态性(rs712)干扰KRAS基因3'非翻译区(3'-UTR)与let-7g相互作用的分子机制,及其与慢性阻塞性肺疾病(COPD)患者肺癌发生的相关性。

材料与方法

在本研究中,我们利用荧光素酶报告系统证实KRAS是肺癌细胞中let-7g的靶基因,并且将rs712次要等位基因导入3'-UTR会显著损害miRNA/mRNA相互作用。此外,共获取了35份肺组织样本(TT型:17份,TG型:12份,GG型:6份),并测定了let-7g和KRAS的表达水平。

结果

我们发现各基因型组间let-7g水平相似,GG基因型组中KRAS的浓度显著高于TT或GT基因型组。同时,我们发现与TT和GT基因型相比,GG基因型的COPD患者患肺癌的风险显著更高(优势比OR = 6.83,P = 0.0081)。

结论

我们的研究表明KRAS基因3'-UTR rs712多态性干扰了miRNA/mRNA相互作用,并表明次要等位基因与COPD患者肺癌发生风险升高相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/e47d0ad8cea5/copd-10-1641Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/661c8f5fa1f5/copd-10-1641Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/d6891a2a7426/copd-10-1641Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/be98e4e1fd14/copd-10-1641Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/502e4be7f362/copd-10-1641Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/e47d0ad8cea5/copd-10-1641Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/661c8f5fa1f5/copd-10-1641Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/d6891a2a7426/copd-10-1641Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/be98e4e1fd14/copd-10-1641Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/502e4be7f362/copd-10-1641Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7587/4544728/e47d0ad8cea5/copd-10-1641Fig5.jpg

相似文献

1
A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.KRAS基因3'-非翻译区的一个变体破坏了它与hsa-let-7g的相互作用,并促进慢性阻塞性肺疾病(COPD)患者肺癌的发生。
Int J Chron Obstruct Pulmon Dis. 2015 Aug 17;10:1641-9. doi: 10.2147/COPD.S83596. eCollection 2015.
2
A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.一个位于 let-7g 结合位点的单核苷酸多态性通过调节 KRAS 诱导的细胞增殖影响甲状腺结节的倍增时间。
J Cell Physiol. 2019 Dec;234(12):23437-23447. doi: 10.1002/jcp.28912. Epub 2019 May 31.
3
A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.KRAS基因3'-非翻译区的单核苷酸多态性破坏了与let-7a的相互作用,并增强了骨肉瘤细胞的转移潜能。
Int J Mol Med. 2016 Sep;38(3):919-26. doi: 10.3892/ijmm.2016.2661. Epub 2016 Jul 4.
4
Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.let-7 KRAS基因rs712多态性与乳腺癌风险的关联。
Genet Mol Res. 2015 Dec 14;14(4):16913-20. doi: 10.4238/2015.December.14.19.
5
A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.KRAS基因3'非翻译区的let-7结合位点多态性rs712与胃癌风险增加相关。
Tumour Biol. 2013 Oct;34(5):3159-63. doi: 10.1007/s13277-013-0885-x. Epub 2013 Jun 2.
6
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.KRAS基因3'非翻译区中一个与let-7微小RNA互补位点的单核苷酸多态性增加了非小细胞肺癌的发病风险。
Cancer Res. 2008 Oct 15;68(20):8535-40. doi: 10.1158/0008-5472.CAN-08-2129.
7
A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.KRAS 3'非翻译区中一个let-7微小RNA结合位点多态性与北印度人群胆囊癌风险增加及生存率降低相关。
J Cancer Res Clin Oncol. 2016 Dec;142(12):2577-2583. doi: 10.1007/s00432-016-2254-9. Epub 2016 Sep 12.
8
Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.miR-1827 结合位点中 MYCL1 的遗传变异改变小细胞肺癌的易感性。
Cancer Res. 2011 Aug 1;71(15):5175-81. doi: 10.1158/0008-5472.CAN-10-4407. Epub 2011 Jun 15.
9
A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.一种let-7 KRAS基因rs712多态性增加结直肠癌风险。
Tumour Biol. 2014 Jan;35(1):831-5. doi: 10.1007/s13277-013-1114-3. Epub 2013 Aug 24.
10
A single nucleotide polymorphism in 3' untranslated region of epithelial growth factor receptor confers risk for pulmonary hypertension in chronic obstructive pulmonary disease.上皮生长因子受体3'非翻译区的单核苷酸多态性赋予慢性阻塞性肺疾病患者患肺动脉高压的风险。
Cell Physiol Biochem. 2015;36(1):166-78. doi: 10.1159/000374061. Epub 2015 Apr 30.

引用本文的文献

1
MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.利用纳米载体将微小RNA作为改善慢性阻塞性肺疾病的有前景的药物递送靶点:综述
Mol Cell Biochem. 2025 Mar;480(3):1431-1448. doi: 10.1007/s11010-024-05110-0. Epub 2024 Sep 10.
2
Screening of potential key ferroptosis-related genes in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中潜在关键铁死亡相关基因的筛选。
Int J Chron Obstruct Pulmon Dis. 2023 Dec 1;18:2849-2860. doi: 10.2147/COPD.S422835. eCollection 2023.
3
Upregulation Attenuated the KRAS-PI3K-Rac1-Akt Axis-Mediated Bioenergetic Functions.

本文引用的文献

1
Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.肺癌和卵巢癌病例中 KRAS 基因 3'非翻译区的广泛序列变异。
Cell Cycle. 2014;13(6):1030-40. doi: 10.4161/cc.27941. Epub 2014 Feb 3.
2
Kras as a key oncogene and therapeutic target in pancreatic cancer.Kras作为胰腺癌中的关键癌基因和治疗靶点。
Front Physiol. 2014 Jan 21;4:407. doi: 10.3389/fphys.2013.00407. eCollection 2013.
3
A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
上调减弱了KRAS-PI3K-Rac1-Akt轴介导的生物能量功能。
Cells. 2023 Sep 19;12(18):2313. doi: 10.3390/cells12182313.
4
The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1.miRNA hsa-let-7g 通过靶向 HOXB1 促进肺癌增殖并抑制细胞凋亡。
Yonsei Med J. 2020 Mar;61(3):210-217. doi: 10.3349/ymj.2020.61.3.210.
5
Prediction of microRNA and gene target from an integrated network in chronic obstructive pulmonary disease based on canonical correlation analysis.基于典型相关分析的慢性阻塞性肺疾病整合网络中微小RNA和基因靶点预测
Technol Health Care. 2018;26(S1):121-134. doi: 10.3233/THC-174257.
6
Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers.慢性阻塞性肺疾病:微小RNA和外泌体作为新的诊断和治疗生物标志物
J Res Med Sci. 2018 Mar 27;23:27. doi: 10.4103/jrms.JRMS_1054_17. eCollection 2018.
7
Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.Let-7-KRAS基因rs712 G>T多态性与中国人群癌症风险的显著关联:一项荟萃分析。
Oncotarget. 2017 Feb 21;8(8):13863-13871. doi: 10.18632/oncotarget.14672.
KRAS基因3'非翻译区的let-7结合位点多态性rs712与胃癌风险增加相关。
Tumour Biol. 2013 Oct;34(5):3159-63. doi: 10.1007/s13277-013-0885-x. Epub 2013 Jun 2.
4
Lung cancer in patients with chronic obstructive pulmonary disease-- incidence and predicting factors.慢性阻塞性肺疾病患者的肺癌——发病率和预测因素。
Am J Respir Crit Care Med. 2011 Oct 15;184(8):913-9. doi: 10.1164/rccm.201103-0430OC.
5
MicroRNAs in development and disease.微小 RNA 在发育和疾病中的作用。
Physiol Rev. 2011 Jul;91(3):827-87. doi: 10.1152/physrev.00006.2010.
6
COPD and lung cancer linked at a molecular genetic level.
Chest. 2011 Jul;140(1):266-267. doi: 10.1378/chest.11-0220.
7
Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.KRAS 突变和多态性对口腔鳞状细胞癌风险和预后的影响。
Head Neck. 2012 May;34(5):663-6. doi: 10.1002/hed.21792. Epub 2011 Jun 17.
8
MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer.微小 RNA let-7f 通过靶向人胃癌中的 MYH9 抑制肿瘤侵袭和转移。
PLoS One. 2011 Apr 18;6(4):e18409. doi: 10.1371/journal.pone.0018409.
9
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis.3'-非翻译区 KRAS 变异与三阴性乳腺癌:病例对照与遗传分析。
Lancet Oncol. 2011 Apr;12(4):377-86. doi: 10.1016/S1470-2045(11)70044-4. Epub 2011 Mar 22.
10
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.KRAS rs61764370 在浸润性上皮性卵巢癌中的作用:对临床检测的影响。
Clin Cancer Res. 2011 Jun 1;17(11):3742-50. doi: 10.1158/1078-0432.CCR-10-3405. Epub 2011 Mar 8.